Literature DB >> 11672957

Determination of the disappearance rate of iodine-125 labelled oils from the injection site after intramuscular and subcutaneous administration to pigs.

S W Larsen1, E Rinvar, O Svendsen, J Lykkesfeldt, G J Friis, C Larsen.   

Abstract

The rate of disappearance of clinically used vegetable oils, Viscoleo, sesame oil, castor oil and isopropyl myristate, from the injection site after intramuscular (i.m.) or subcutaneous (s.c.) administration to pigs were determined by using a non-invasive gamma-scintigraphy method. All the oil vehicles were spiked with 2.5% (v/v) (125)I-triolein and six injections of 1.9 ml were given to each of 12 pigs. No significant difference (ANOVA) in disappearance rate of each individual oil vehicle from the different injection sites was observed after administration of the oils: i.m. in the lower back, s.c. in the neck and s.c. in the mid-back. Likewise, no inter-individual difference between the pigs was observed. The half-life of 14 days for Viscoleo was significantly smaller than those of the other oil vehicles (P<0.0001), i.e. 23,20,20 days for sesame oil, castor oil and isopropyl myristate, respectively. Due to the spreading effect of the oils and reflux of the oils through the injection canal, the half-lives were calculated omitting the data for the first sampling day.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11672957     DOI: 10.1016/s0378-5173(01)00860-2

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

Review 1.  Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.

Authors:  Susan Weng Larsen; Claus Larsen
Journal:  AAPS J       Date:  2009-11-06       Impact factor: 4.009

2.  Physico-chemical characterization of sesame oil derivatives.

Authors:  Iacopo Zanardi; Valter Travagli; Alessandro Gabbrielli; Luisa Chiasserini; Velio Bocci
Journal:  Lipids       Date:  2008-08-05       Impact factor: 1.880

3.  ELQ-331 as a prototype for extremely durable chemoprotection against malaria.

Authors:  Martin J Smilkstein; Sovitj Pou; Alina Krollenbrock; Lisa A Bleyle; Rozalia A Dodean; Lisa Frueh; David J Hinrichs; Yuexin Li; Thomas Martinson; Myrna Y Munar; Rolf W Winter; Igor Bruzual; Samantha Whiteside; Aaron Nilsen; Dennis R Koop; Jane X Kelly; Stefan H I Kappe; Brandon K Wilder; Michael K Riscoe
Journal:  Malar J       Date:  2019-08-27       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.